Enhanced transdermal bioavailability of testosterone propionate via surfactant-modified ethosomes

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 3051-3060

  Meng, Shu ^a   Chen, Zaixing ^b   Yang, Liqun ^a   Zhang, Wei ^a   Liu, Danhua ^a   Guo, Jing ^a   Guan, Yanmin ^a   Li, Jianxin ^a  

^a Liaoning Research Institute of Family Planning   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Confocal laser scanning microscopy; Liposomes; Surfactant modified ethosomes; Testosterone propionate

Indexed keywords

CETRIMIDE; CREMOPHOR; CREMOPHOR EL 35; DRUG CARRIER; DYE; ETHOSOME; LIPOSOME; RHODAMINE RED; SURFACTANT; TESTOSTERONE PROPIONATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMICAL PARAMETERS; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG STABILITY; DRUG TRANSPORT; IN VITRO STUDY; IN VIVO STUDY; LIGHT SCATTERING; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; POLYDISPERSITY; SKIN PENETRATION; SUSTAINED RELEASE FORMULATION; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

CONFOCAL LASER SCANNING MICROSCOPY; LIPOSOMES; SURFACTANT-MODIFIED ETHOSOMES; TESTOSTERONE PROPIONATE;

ADMINISTRATION, CUTANEOUS; ANIMALS; BIOLOGICAL AVAILABILITY; CETRIMONIUM COMPOUNDS; DRUG STABILITY; ETHANOL; LIPOSOMES; MALE; MICE; MICROSCOPY, CONFOCAL; PARTICLE SIZE; POLYETHYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; SKIN; SKIN ABSORPTION; SOLUBILITY; SURFACE-ACTIVE AGENTS; TESTOSTERONE PROPIONATE;

EID: 84881592187     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S46748     Document Type: Article

References (28)

1. Bagatell CJ, Bremner WJ. Androgens in men - uses and abuses. N Engl J Med. 1996;334(11):707-714.
2. Basaria S, Dobs AS. Hypogonadism and androgen replacement therapy in elderly men. Am J Med 2001;110(7):563-572.
3. Yassin AA, Haffejee M. Testosterone depot injection in male hypogonadism: a critical appraisal. Clin Interv Aging. 2007;2(4):577-590.
4. Tan RS, Culberson JW. An integrative review on current evidence of testosterone replacement therapy for the andropause. Maturitas. 2003;45(1):15-27.
5. Nieschlag E, Büchter D, Von Eckardstein S, Abshagen K, Simoni M, Behre HM. Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men. Clin Endocrinol (Oxf). 1999;51(6):757-763.
6. Behre HM, Wang C, Handelsman DJ, Nieschlag E. Pharmacology of testosterone preparations. In: Neischlag E, Behre HM, editors. Testosterone: Action, Deficiency, Substitution. Cambridge: Cambridge University Press; 2004:405-445.
7. Kaplun-Frischoff Y, Touitou E. Testosterone skin permeation enhancement by menthol through formation of eutectic with drug and interaction with skin lipids. J Pharm Sci. 1997;86(12):1394-1399.
8. Dayan N, Touitou E. Carriers for skin delivery of trihexyphenidyl HCl:ethosomes vs liposomes. Biomaterials. 2000;21(18):1879-1885.
9. Godin B, Touitou E. Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. J Control Release. 2004;94(2-3):365-379.
10. Paolino D, Lucania G, Mardente D, Alhaique F, Fresta M. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Control Release. 2005;106(1-2):99-110.
11. Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM. Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. Int J Pharm. 2006;322(1-2):60-66.
12. Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release. 2000;65(3): 403-418.
13. Jain HP, J. Joshi, K. Patel, P. Upadhyay U.M., ethosome: a novel drug carrier. International journal of comprehensive pharmacy. 2011;7(1):1-4.
14. Touitou E, Godin, B. Weiss, C. Enhanced delivery of drugs into and across the skin by ethosomal carriers. Drug Dev Res. 2000;50:(3-4)406-415.
15. Dubey V, Mishra D, Jain NK. Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery. Eur J Pharm Biopharm. 2007;67(2):398-405.
16. Ainbinder D, Touitou E. Testosterone ethosomes for enhanced transdermal delivery. Drug Deliv. 2005;12(5):297-303.
17. Yang S, Chen J, Zhao D, Han D, Chen X. Comparative study on preparative methods of DC-Chol/DOPE liposomes and formulation optimization by determining encapsulation efficiency. Int J Pharm. 2012;434(1-2):155-160.
18. Yu BT, Zhang ZR. Preparation and in vitro Drug-release Behavior of Andrographolide Liposomes. Chinese Journal of Pharmaceuticals 2009;40(2):114-116.
19. Bhatia A, Kumar R, Katare OP. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation. J Pharm Pharm Sci. 2004;7(2):252-259.
20. Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev 2004;56(5):603-618.
21. Rao Y, Zheng F, Zhang X, Gao J, Liang W. In vitro percutaneous permeation and skin accumulation of finasteride using vesicular ethosomal carriers. AAPS PharmSciTech. 2008;9(3):860-865.
22. Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci. 2001;14(2):101-114.
23. Barupal AK, Gupta V, Ramteke S. Preparation and Characterization of Ethosomes for Topical delivery of Aceclofenac. Indian J Pharm Sci. 2010;72(5):582-586.
24. Dubey V, Mishra D, Asthana A, Jain NK. Transdermal delivery of a pineal hormone: melatonin via elastic liposomes. Biomaterials. 2006;27(18):3491-3496.
25. Mishra D, Dubey V, Asthana A, Saraf DK, Jain NK. Elastic liposomes mediated transcutaneous immunization against Hepatitis B. Vaccine. 2006;24(22):4847-4855.
26. Jain S, Jain N, Bhadra D, Tiwary AK, Jain NK. Transdermal delivery of an analgesic agent using elastic liposomes: preparation, characterization and performance evaluation. Curr Drug Deliv. 2005;2(3):223-233.
27. Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM. Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm. 2007;332(1-2):1-16.
28. Snabes MC, Simes SM. Approved hormonal treatments for HSDD: an unmet medical need. J Sex Med. 2009;6(7):1846-1849.